Cancer has existed throughout recorded human history, but scientists continue to investigate the enormous range of biological, environmental and infectious factors capable of influencing its development. Among those factors is a connection unfamiliar to many Americans: certain parasitic infections can increase the risk of particular cancers.
The relationship is neither theoretical nor merely based on similarities between parasites and tumors. International cancer researchers have established that several parasitic infections are carcinogenic to humans. Certain liver flukes are associated with cancer of the bile ducts, while infection with the blood fluke Schistosoma haematobium is associated with bladder cancer. These organisms can persist in human tissue and produce chronic inflammation and injury, creating biological conditions capable of contributing to malignant changes over time.
That evidence, however, requires an important boundary. Scientists have established links between specific parasites and specific cancers; they have not established that parasites are a general cause of cancer or that parasites are routinely present inside human tumors. Cancer encompasses hundreds of diseases influenced by genetics, aging, tobacco, alcohol, radiation, infections, environmental exposures, obesity and numerous other factors. Parasitic infection represents one documented component of that much larger field.
Parasites are also not exclusively a problem of distant tropical regions. Humans can acquire parasitic infections through contaminated food or water, insect vectors, soil, travel and, depending on the organism, animals. Zoonotic diseases are capable of moving between animals and humans, although the parasites routinely treated in household pets and livestock are not necessarily the same organisms responsible for common human infections.
That distinction helps explain why veterinary deworming practices cannot be directly translated into recommendations for routine human deworming. Dogs, cats, horses and livestock may receive preventive parasite treatment because their exposure patterns, parasite prevalence and veterinary risk profiles warrant it. Human public-health programs instead rely heavily on local prevalence, epidemiology and individual risk.
Large-scale human deworming does occur around the world. The World Health Organization recommends periodic preventive treatment for certain populations living in areas where soil-transmitted helminth infections are endemic. In communities with sufficiently high prevalence, children and other at-risk groups may receive antiparasitic medication without first undergoing individual diagnostic testing. These programs are designed to reduce illness caused by parasitic infection rather than to prevent cancer.
The United States does not employ comparable nationwide mass-deworming programs because the epidemiological circumstances are different. That does not mean parasitic infections do not occur in the country or that physicians should disregard them. Exposure history, travel, symptoms, immune status and other risk factors can provide legitimate reasons for diagnostic testing. It does mean that evidence supporting mass treatment in a highly endemic community cannot automatically be applied to the entire U.S. population.
Environmental exposures present a separate and increasingly important field of cancer research. Per- and polyfluoroalkyl substances, commonly known as PFAS or “forever chemicals,” have drawn substantial scientific attention because some remain in the human body for prolonged periods and have been associated with several adverse health effects. Researchers continue examining associations between particular PFAS exposures and certain cancers.
What has not been established is a biological chain in which PFAS weaken the body, parasites consequently flourish and cancer then develops. The same caution applies to claims involving food preservatives, medications and the intestinal microbiome. Immunosuppressive drugs can increase susceptibility to certain infections, and medications that alter stomach acidity or intestinal conditions can affect the gastrointestinal environment, but those observations do not demonstrate a generalized parasite-to-cancer pathway.
The internet has complicated this discussion considerably. Antiparasitic cleanses, herbal deworming mixtures, ivermectin regimens, detox programs, juicing protocols and theories connecting parasites with cancer circulate widely on social media. Their popularity demonstrates substantial public interest in parasites, but popularity is not evidence of therapeutic effectiveness. Finding that a particular parasite can contribute to a particular cancer does not establish that antiparasitic drugs or cleanses can treat cancers unrelated to those infections.
Historical medicine adds another intriguing dimension, although ancient descriptions must be interpreted cautiously. Egyptian, Greek, Indian and Chinese medical traditions all attempted to explain abnormal growths and serious disease using the biological concepts available at the time. The word “cancer” itself traces to the Greek karkinos, or crab, reflecting an ancient description of the appearance of some tumors. Those observations offer valuable insight into the history of medicine, but they cannot be treated as scientific confirmation that ancient physicians understood cancer as a parasitic disease.
Modern science provides something considerably more concrete. Certain parasites unquestionably cause or contribute to certain human diseases, and several parasitic infections are recognized carcinogenic hazards. Chronic infection, persistent inflammation and repeated tissue injury are among the mechanisms researchers have investigated in explaining those relationships.
The unanswered questions are where the subject becomes particularly important. Scientists continue studying interactions among infection, inflammation, immune function, environmental exposures and cancer. Improved surveillance and diagnostic awareness could also provide a clearer picture of parasitic disease within the United States.
The parasite-cancer connection therefore deserves neither dismissal nor exaggeration. There is compelling evidence that particular parasitic infections can contribute to the development of particular cancers, making prevention and treatment of those infections a legitimate component of cancer prevention in affected populations. What science has not demonstrated is that parasites broadly account for America’s cancer burden or that routine deworming would reduce cancer rates in the general U.S. population.
The established connection is significant enough without stretching it beyond the evidence. Understanding exactly where parasites intersect with cancer, and where they do not, offers a stronger foundation for public health than either ignoring the relationship or assigning it a role science has yet to prove.